Story · Medicine & Biotech

Katsuaki Maehara: Key Clinical Trials Shaping Perioperative Chemo-Immunotherapy in NSCLC

1 outlet · first reported by OncoDaily on

Katsuaki Maehara, Director of Medical Education Colleagues, shared on X: “Perioperative chemo-immunotherapy. Updated the summary slide. 1. Title: Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study
    Katsuaki Maehara: Key Clinical Trials Shaping Perioperative Chemo-Immunotherapy in NSCLC

    Katsuaki Maehara, Director of Medical Education Colleagues, shared on X: “Perioperative chemo-immunotherapy. Updated the summary slide. 1. Title: Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.